Laminar Pharmaceuticals
Next generation medicines!
This information is confidential, do not share or copy.
You can visit their website or
Other files:
Equity Story Orphan Drug Designation by FDA Orphan Drug Designation by EMA Premio Onda Cero Investigación y Ciencia 2022 Orphan Drug Designation by EMA 2 LAM561 mechanism of action - selected papers 2005-2012 Laminar Technology Platform: Molecular Basis of Melitherapy LAM561 Clinical Efficacy and Safety refports (Clinical Trials in Humans, phases 1A, 1B, 2A)
Under evaluation at least till: 7th June 2019
KEEP REVIEWING
